Literature DB >> 21402421

Is inflammation linked to thrombogenesis in atrial fibrillation?

Shu-Ping Gao1, Xin-Tao Deng2, Li-Jun Ge1, Hong Luan1, Jin-Guo Zheng2, Chu Chen3, Min-Hui Jiang3, Min Pan4.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21402421     DOI： 10.1016/j.ijcard.2011.02.046

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  Association of Interleukin-10 promotor polymorphisms with atrial fibrillation in Han Chinese.

Authors:  Dong-Dong Zheng; Shun-Nian Ji; Chu Chen; Xin-Tao Deng; Ya-Min Su; Hai-Yan Pan; Xing-Xing Cai; Xiao-Fei Li; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  A functional single-nucleotide polymorphism in interleukin-6 promoter is associated with p wave dispersion in hypertensive subjects with atrial fibrillation.

Authors:  Hai-Hua Geng; Rui Li; Ya-Min Su; Hai-Yan Pan; Min Pan; Xiao-Ping Ji
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 3.  Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke.

Authors:  Charles C Esenwa; Mitchell S Elkind
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

4.  Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension.

Authors:  Jing Li; Jie Song; Min-Hui Jiang; Jin-Guo Zheng; Shu-Ping Gao; Jian-Hua Zhu; Min Pan
Journal:  J Interferon Cytokine Res       Date:  2012-08-27       Impact factor: 2.607

5.  Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Authors:  Mariana S Parahuleva; Sandip Kanse; Hans Hölschermann; Kirila Zheleva; Daniel Zandt; Michael Worsch; Behnoush Parviz; Norbert Güttler; Harald Tillmanns; Andreas Böning; Ali Erdogan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

6.  Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.

Authors:  Knut Tore Lappegård; Monica Pop-Purceleanu; Waander van Heerde; Joe Sexton; Indira Tendolkar; Gheorghe Pop
Journal:  J Neuroinflammation       Date:  2013-06-28       Impact factor: 8.322

7.  Right Atrial Fluorodeoxyglucose Uptake Is a Risk Factor for Stroke and Improves Prediction of Stroke Above the CHA2DS2-VASc Score in Patients With Atrial Fibrillation.

Authors:  Bing Wang; Yiduo Xu; Peng Wan; Shan Shao; Feifei Zhang; Xiaoliang Shao; Jianfeng Wang; Yuetao Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-08

8.  Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension.

Authors:  Min-Hui Jiang; Ya-Min Su; Jian-Zhong Tang; Yan-Bo Shen; Xin-Tao Deng; Ding-Shan Yuan; Jie Wu; Min Pan; Zhong-Wei Huang
Journal:  Clinics (Sao Paulo)       Date:  2013-11       Impact factor: 2.365
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.